Variants of FGFR3, including S249C have been reported previously in HPV+ HNSCC, but have to our knowledge not previously been correlated to clinical outcome in HPV+ TSCC/BOTSCC [30, 31, 33, 35]. This evidence concerns the gene FGFR3 and head and neck squamous cell carcinoma.